SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Human Genome Sciences, Inc. (HGSI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (66)3/1/1997 2:42:00 PM
From: Miles Rhyne Hoffman, CFA   of 1127
 
Brokers may have a vested interested to slightly under-price a NEW issue, but when a stock is already trading the secondary comes out pretty much at the current price. And even with new issues, if demand is strong brokers will up the proposed offering price.

I seriously doubt they look at underpricing by 20%. Admittedly brokers are not all-knowing, all-seeing, but if they did 20% underprice I am sure studies would have shown this by now. Can you point me to an academic study to support your theory?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News